# BEOVU
> **BLA761125** · Biologics License Application · Sponsor: NOVARTIS PHARMS CORP · Approved 2019-10-07
## Drug
- **FDA Application Number:** BLA761125
- **Application type:** Biologics License Application
- **Brand name:** BEOVU
- **Generic name:** BROLUCIZUMAB
- **Active ingredients:** brolucizumab-dbll
- **Dosage form:** INJECTABLE
- **Route:** INTRAVITREAL
- **Marketing status:** Prescription
- **Sponsor:** NOVARTIS PHARMS CORP
- **Manufacturer:** Novartis Pharmaceuticals Corporation
- **First approval:** 2019-10-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761125)
---
*AI Analytics · CC0 1.0*